Authors: Dr. K. R. Joshi, Harshu Bhandari
Abstract: Drug resistance remains a significant challenge in cancer treatment, limiting the efficacy and long-term success of various therapeutic interventions. The emergence of resistant cancer cells poses a major obstacle to achieving durable remission and improving patient outcomes. This paper reviews the mechanisms underlying drug resistance in cancer and explores novel strategies that have shown promise in overcoming this resistance. Furthermore, it discusses the potential future perspectives and advancements that may revolutionize cancer treatment approaches and enhance the chances of achieving successful outcomes.
Keywords: Drug resistance, Cancer treatment, Biomarkers, Rational design, Heterogeneity
Full Issue
| View or download the full issue | PDF 1-15 |